COVID-19 (coronavirus)

Compound Tested for Alcoholic Liver Disease

Researchers at Cedars-Sinai recently found that a synthetic compound improved the protection of the liver against injury in an animal model for alcoholic hepatitis.

Ekihiro Seki, MD, PhD

Ekihiro Seki, MD, PhD